United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - lansoprazole (unii: 0k5c5t2qpg) (lansoprazole - unii:0k5c5t2qpg) - lansoprazole delayed-release orally disintegrating tablets are indicated in adults for short-term treatment (for four weeks) for healing and symptom relief of active duodenal ulcer [see clinical studies (14.1)]. triple therapy: lansoprazole delayed-release orally disintegrating tablets /amoxicillin/clarithromycin lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin plus clarithromycin as triple therapy is indicated in adults for the treatment of patients with h. pylori infection and duodenal ulcer disease (active or one year history of a duodenal ulcer) to eradicate h. pylori. eradication of h. pylori has been shown to reduce the risk of duodenal ulcer recurrence [see clinical studies (14.2)]. please refer to the full prescribing information for amoxicillin and clarithromycin. dual therapy: lansoprazole delayed-release orally disintegrating tablets /amoxicillin lansoprazole delayed-release orally disintegrating tablets in combination with amoxicillin as dual therapy

United States - English - NLM (National Library of Medicine)

e.r. squibb & sons, l.l.c. - atazanavir sulfate (unii: 4mt4vie29p) (atazanavir - unii:qzu4h47a3s) - atazanavir 150 mg - reyataz® is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and in pediatric patients 3 months and older weighing at least 5 kg. limitations of use: reyataz is contraindicated: table 6 displays drugs that are contraindicated with reyataz. drug class drugs within class that are contraindicated with reyataz alpha 1-adrenoreceptor antagonist alfuzosin anticonvulsants carbamazepine, phenobarbital, phenytoin antiarrhythmics amiodarone (with ritonavir), quinidine (with ritonavir) antimycobacterials rifampin antineoplastics apalutamide, encorafenib, irinotecan, ivosidenib antipsychotics lurasidone (with ritonavir), pimozide benzodiazepines orally administered midazolama , triazolam ergot derivatives dihydroergotamine, ergonovine, ergotamine, methylergonovine gi motility agent cisapride hepatitis c direct-acting antivirals elbasvir/grazoprevir; glecaprevir/pibrentasvir herbal products st. john’s wort (hypericum perforatum) lipid-modifying agents: lomitapide, l

United States - English - NLM (National Library of Medicine)

macleods pharmaceuticals limited - zolmitriptan (unii: 2fs66th3yw) (zolmitriptan - unii:2fs66th3yw) - zolmitriptan 2.5 mg - zolmitriptan is indicated for the acute treatment of migraine with or without aura in adults. limitations of use - only use zolmitriptan if a clear diagnosis of migraine has been established. if a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan are administered to treat any subsequent attacks. - zolmitriptan is not indicated for the prevention of migraine attacks.  - safety and effectiveness of zolmitriptan have not been established for cluster headache. zolmitriptan is contraindicated in patients with: - ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), other significant underlying cardiovascular disease, or coronary artery vasospasm including prinzmetal's angina [see warnings and precautions (5.1) ]. - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders [see warnings and precautions (

United States - English - NLM (National Library of Medicine)

tersera therapeutics llc - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - qmiiz odt is indicated for relief of the signs and symptoms of osteoarthritis in adults [see clinical studies (14.1) ]. qmiiz odt is indicated for relief of the signs and symptoms of rheumatoid arthritis in adults [see clinical studies (14.1) ]. qmiiz odt is indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in pediatric patients who weigh greater than or equal to 60 kg [see dosage and administration (2.4) and clinical studies (14.2) ]. qmiiz odt is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [see warnings and precautions (5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8) ] - in the setting of coronary artery bypass

United States - English - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - chlorpromazine hydrochloride (unii: 9wp59609j6) (chlorpromazine - unii:u42b7vya4p) - for the management of manifestations of psychotic disorders. for the treatment of schizophrenia. to control nausea and vomiting. for relief of restlessness and apprehension before surgery. for acute intermittent porphyria. as an adjunct in the treatment of tetanus. to control the manifestations of the manic type of manic-depressive illness. for relief of intractable hiccups. for the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability and poor frustration tolerance. do not use in patients with known hypersensitivity to phenothiazines. do not use in comatose states or in the presence of large amounts of central nervous system depressants (alcohol, barbiturates, narcotics, etc.).

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - raltegravir potassium (unii: 43y000u234) (raltegravir - unii:22vkv8053u) - raltegravir 400 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

reckitt benckiser ireland ltd - ispaghula husks - granules - 3.5 gram(s) - bulk-forming laxatives; ispaghula (psylla seeds)

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - olanzapine - orodispersible tablet - 10 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; olanzapine

Israel - English - Ministry of Health

abic marketing ltd, israel - benzydamine hydrochloride - lozenges - benzydamine hydrochloride 3 mg - benzydamine - rogaron is used for symptomatic local treatment of acute sore throat in adults and children over 6 years of age.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

vitaflo international ltd - liquid